Biggest News Aggregation in the World
📰 Daniel De Roulet News

Daniel De Roulet News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Daniel De Roulet. Real-time updates on events, politics, business and more.

AbbVie buys exclusive right to acquire Mitokinin's Parkinson's asset

AbbVie buys exclusive right to acquire Mitokinin’s Parkinson’s asset Company can acquire asset following the completion of IND enabling studies AbbVie has purchased an exclusive right to acquire Mitokinin’s lead PINK1 asset following the completion of IND enabling studies for Parkinson’s disease. Mitokinin is based on technology discovered at the University of California, San Francisco (UCSF) by company co-founders Nicholas Hertz and Kevan Shokat. Hertz and Shokat moved the company int...
United States San Francisco Nicholas Hertz Kevan Shokat University Of California Mission Biocapital
Source: pmlive.com

Mitokinin, Inc., Enters into Purchase Right Agreement with AbbVie

Share this article Share this article SAN FRANCISCO, March 2, 2021 /PRNewswire/ -- Mitokinin, Inc., a biotechnology company developing PINK1-targeted therapeutics for the treatment of neurodegenerative diseases, announced today that AbbVie, a leading global biopharmaceutical company, has purchased an exclusive right to acquire Mitokinin following completion of IND enabling studies on Mitokinins lead PINK1 compound. Based on technology discovered at UCSF by Mitokinin co-founders Nicholas Hertz ...
San Francisco United States Nicholas Hertz Michaeld Taylor Kevan Shokat Mitokinin Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science